Post-earnings recap
Reported
Thu, May 7, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
38%
Twist Bioscience's earnings report indicates ongoing challenges, particularly reflected in their EPS miss. The stock reacted negatively, dropping 1.48%, likely due to investor concerns about the company's short-term performance. Without revenue figures or guidance, uncertainty remains about their future direction.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.85 | N/A | -18.06% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about the impact of external factors on their operations. They remain focused on strategic initiatives to drive future growth.
Management highlighted ongoing challenges in the current market environment.
They emphasized their commitment to long-term growth despite short-term setbacks.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—